• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IRIDEX Corporation - Common Stock (NQ:IRIX)

0.9900 -0.3600 (-26.67%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about IRIDEX Corporation - Common Stock

< Previous 1 2 Next >
News headline image
Iridex Reports Fourth Quarter and Full Year 2025 Financial Results
March 26, 2026
Strong Q4 and Full Year 2025 Revenue Performance Underpinned by Continued Operational Efficiencies 
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026
March 12, 2026
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Announces Plans to Relocate Headquarters
February 02, 2026
Move expected to generate significant cost savings 
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025
January 12, 2026
Demonstrating continued revenue growth, operational efficiencies and positive cash flow 
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management
December 11, 2025
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment
December 08, 2025
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex to Present at the Sidoti Year-End Virtual Investor Conference
December 05, 2025
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Reports Third Quarter 2025 Financial Results
November 11, 2025
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025
October 28, 2025
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance
September 09, 2025
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Reports Second Quarter 2025 Financial Results
August 12, 2025
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025
July 29, 2025
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema
June 24, 2025
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Reports First Quarter 2025 Financial Results
May 13, 2025
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex to Report First Quarter 2025 Financial Results on May 13, 2025
April 30, 2025
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025
April 14, 2025
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex to Host Strategic Vision Call on April 16, 2025
April 09, 2025
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Reports Fourth Quarter and Full Year 2024 Financial Results
March 27, 2025
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Announces Strategic Investment in the Company
March 19, 2025
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Comments on Recent Stock Price Volatility
March 14, 2025
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025
March 13, 2025
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2024
January 14, 2025
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management
December 18, 2024
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Comments on Changing Glaucoma Reimbursement Landscape
November 19, 2024
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Reports Third Quarter 2024 Financial Results
November 12, 2024
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024
November 04, 2024
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Appoints Patrick Mercer as Chief Executive Officer
October 03, 2024
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Reports Second Quarter 2024 Financial Results
August 08, 2024
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Announces Convertible Note Financing
August 05, 2024
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024
July 30, 2024
From IRIDEX Corporation
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap